Lanean...
Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis
BACKGROUND & OBJECTIVES: Advanced epithelial ovarian cancer (EOC) is associated with dismal outcome and progression-free survival (PFS) shortens with each subsequent relapse. For patients with recurrent and platinum refractory disease, therapeutic options are limited. Oral metronomic therapy (OM...
Gorde:
| Argitaratua izan da: | Indian J Med Res |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer - Medknow
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7038810/ https://ncbi.nlm.nih.gov/pubmed/32048620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_2030_18 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|